Arteriovenous malformations in mice lacking activin receptor-like kinase-1

被引:334
作者
Urness, LD
Sorensen, LK
Li, DY [1 ]
机构
[1] Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA
[3] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT USA
[4] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/81634
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The mature circulatory system is comprised of two parallel, yet distinct, vascular networks that carry blood to and from the heart. Studies have suggested that endothelial tubes are specified as arteries and veins at the earliest stages of angiogenesis, before the onset of circulation(1-4). To understand the molecular basis for arterial-venous identity, we have focused our studies on a human vascular dysplasia, hereditary haemorrhagic telangiectasia (HHT), wherein arterial and venous beds fail to remain distinct. Genetic studies have demonstrated that HHT can be caused by loss-of-function mutations in the gene encoding activin receptor-like kinase-1 (ACVRL1; ref. 5). ACVRL1 encodes a type I receptor for the TGF-P superfamily of growth factors(6-8). At the earliest stage of vascular development, mice lacking Acvrl1 develop large shunts between arteries and veins, downregulate arterial Efnb2 and fail to confine intravascular haematopoiesis to arteries. These mice die by mid-gestation with severe arteriovenous malformations resulting from fusion of major arteries and veins. The early loss of anatomical, molecular and functional distinctions between arteries and Veins indicates that Acvrl1 is required for developing distinct arterial and venous vascular beds.
引用
收藏
页码:328 / 331
页数:4
相关论文
共 26 条
[1]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[2]  
Attisano Liliana, 1996, Cytokine and Growth Factor Reviews, V7, P327, DOI 10.1016/S1359-6101(96)00042-1
[3]   DIFFUSE INTRAEMBRYONIC HEMATOPOIESIS IN NORMAL AND CHIMERIC AVIAN DEVELOPMENT [J].
DIETERLENLIEVRE, F ;
MARTIN, C .
DEVELOPMENTAL BIOLOGY, 1981, 88 (01) :180-191
[4]   VASCULARIZATION OF THE MOUSE EMBRYO - A STUDY OF FLK-1, TEK, TIE, AND VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION DURING DEVELOPMENT [J].
DUMONT, DJ ;
FONG, GH ;
PURI, MC ;
GRADWOHL, G ;
ALITALO, K ;
BREITMAN, ML .
DEVELOPMENTAL DYNAMICS, 1995, 203 (01) :80-92
[5]  
FLAMME I, 1992, DEVELOPMENT, V116, P435
[6]  
GADSON PF, 1993, IN VITRO CELL DEV-AN, V29A, P773
[7]   Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development [J].
Gale, NW ;
Yancopoulos, GD .
GENES & DEVELOPMENT, 1999, 13 (09) :1055-1066
[8]  
GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427
[9]   Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development [J].
Gerety, SS ;
Wang, HU ;
Chen, ZF ;
Anderson, DJ .
MOLECULAR CELL, 1999, 4 (03) :403-414
[10]  
Hogan B., 1986, MANIPULATING MOUSE E